kwic
potential
potential
right
off
ON
74
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for potential out of >500 occurrences
545945 occurrences (No.21 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to potential]
545945 occurrences (No.21 in the rank) during 5 years in the PubMed. [cache]
| 74) In this review, we summarize the homeostasis and signaling of HA in healthy tissue, discuss its distribution and ontogeny in the central nervous system (CNS), summarize evidence for its involvement in age-related neurodegeneration and Alzheimer Disease (AD), and assess the potential of HA as a therapeutic target in the CNS. |
| PMID:34634492 DOI:10.1016/j.arr.2021.101485 |
| 2021 Ageing research reviews |
| * Matters of size: Roles of hyaluronan in CNS aging and disease. |
| - Involvement of extracellular matrix (ECM) components in aging and age-related neurodegeneration is not well understood. The role of hyaluronan (HA), a major extracellular matrix glycosaminoglycan, in malignancy and inflammation is gaining new understanding. In particular, the differential biological effects of high molecular weight (HMW-HA) and low molecular weight hyaluronan (LMW-HA), and the mechanism behind such differences are being uncovered. Tightly regulated in the brain, HA can have diverse effects on cellular development, growth and degeneration. In this review, we summarize the homeostasis and signaling of HA in healthy tissue, discuss its distribution and ontogeny in the central nervous system (CNS), summarize evidence for its involvement in age-related neurodegeneration and Alzheimer Disease (AD), and assess the potential of HA as a therapeutic target in the CNS. |
[
right
kwic]
(1)67  to |
(16)4 biomarkers |
(31)3 protective |
(46)2 influencing |
| (2)40 of |
(17)4 mechanism |
(32)3 treatment |
(47)2 inhibitor |
| (3)31 for |
(18)4 targets |
(33)3 value |
(48)2 is |
| (4)12 impact |
(19)4 use |
(34)2 U-shaped |
(49)2 pathways |
| (5)11 *null* | (20)3 areas |
(35)2 adverse |
(50)2 psychosocial |
| (6)10 in |
(21)3 benefit |
(36)2 against |
(51)2 reasons |
| (7)8 role |
(22)3 clinical |
(37)2 barriers |
(52)2 references, |
| (8)8 therapeutic |
(23)3 differences |
(38)2 biomarker |
(53)2 strategy |
| (9)7 as |
(24)3 future |
(39)2 candidate |
(54)2 target |
| (10)6 benefits |
(25)3 health |
(40)2 candidates |
(55)2 that |
| (11)6 risk |
(26)3 importance |
(41)2 diagnostic |
(56)2 therapy |
| (12)5 roles |
(27)3 mechanisms |
(42)2 drug |
(57)2 toxicity |
| (13)5 solutions |
(28)3 mediators |
(43)2 functional |
|
| (14)4 and |
(29)3 molecular |
(44)2 gaps |
|
| (15)4 applications |
(30)3 predictors |
(45)2 harms |
add keyword
--- WordNet output for potential ---